POU5F1 and glioblastoma: Similarly, in patient-derived GSC11 glioblastoma stem cells, glimepiride significantly increased CLIP3 expression and reduced NANOG and OCT4 expression without IR exposure due to its high intrinsic radioresistance (Fig. S5A).